Karyotyping of human chondrocytes in scaffold-assisted cartilage tissue engineering
Source abstract
Abstract
Scaffold-assisted autologous chondrocyte implantation (ACI) is an effective clinical procedure for cartilage repair. The aim of our study was to evaluate the chromosomal stability of human chondrocytes subjected to typical cell culture procedures needed for regenerative approaches in polymer-scaffold-assisted cartilage repair. Chondrocytes derived from post mortem donors and from donors scheduled for ACI were expanded, cryopreserved and re-arranged in polyglycolic acid (PGA)-fibrin scaffolds for tissue culture. Chondrocyte redifferentiation was analyzed by electron microscopy, histology and gene expression analysis. Karyotyping was performed using GTG banding and fluorescence in situ hybridization on a single cell basis. Chondrocytes showed de- and redifferentiation accompanied by the formation of extracellular matrix and induction of typical chondrocyte marker genes like type II collagen in PGA-fibrin scaffolds. Post mortem chondrocytes showed up to 1.7% structural and high numbers of numerical (up to 26.7%) chromosomal aberrations, while chondrocytes from living donors scheduled for ACI showed up to 1.8% structural and up to 1.3% numerical alterations. Cytogenetically, cell culture procedures and PGA-fibrin scaffolds did not significantly alter chromosomal integrity of the chondrocyte genome. Human chondrocytes derived from living donors subjected to regenerative medicine cell culture procedures like cell expansion, cryopreservation and culture in resorbable polymer-based scaffolds show normal chromosomal integrity and normal karyotypes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Silk-based biomaterials and applications · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation10.1056/NEJM199410063311401 ↗
2. Osteochondral transplantation versus autogenous chondrocyte transplantation. A prospective comparative clinical study10.1007/s001040051184 ↗
3. Microfracture: surgical technique and rehabilitation to treat chondral defects10.1097/00003086-200110001-00033 ↗
4. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee10.1302/0301-620X.85B2.13543 ↗
5. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years10.2106/00004623-200710000-00002 ↗
6. Long-term durability of autologous chondrocyte implantation: a multicenter, observational study in US patients10.1177/0363546509348000 ↗
7. Treatment of focal articular cartilage defects in the knee: a systematic review10.1007/s11999-007-0097-z ↗
8. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36months in a randomized trial compared to microfracture10.1177/0363546509350694 ↗
9. Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee
10. Effectiveness of autologous chondrocyte implantation in cartilage repair of the knee: a systematic review of controlled trials10.1016/j.joca.2010.03.005 ↗
11. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial10.1177/0363546508322897 ↗
12. Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits10.1016/S0142-9612(00)00429-4 ↗
13. Second-generation autologous chondrocyte transplantation: MRI findings and clinical correlations at a minimum 5-year follow-up10.1016/j.ejrad.2010.04.002 ↗
14. Repair of articular cartilage defects treated by microfracture and a three-dimensional collagen matrix10.1016/j.biomaterials.2004.09.034 ↗
15. Chondrocyte-seeded type I/III collagen membrane for autologous chondrocyte transplantation: prospective 2-year results in patients with cartilage defects of the knee joint10.1016/j.arthro.2009.12.028 ↗
16. Treatment of articular cartilage defects in horses with polymer-based cartilage tissue engineering grafts10.1016/j.biomaterials.2006.01.008 ↗
17. Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: two year clinical results10.1186/ar2180 ↗
18. Repair of focal cartilage defects with scaffold-assisted autologous chondrocyte grafts: clinical and biomechanical results 48months after transplantation
19. EMA Guideline on human cell-based medicinal products. Doc. Ref. EMEA/CHMP/410869/2006, www.ema.europa.eu 2008.
20. FDA regulatory pathways for knee cartilage repair products10.1097/JSA.0b013e31818cdb97 ↗
21. Influence of the growth factors PDGF-BB, TGF-beta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion10.1002/jor.21007 ↗
22. Genome profiling of chondrosarcoma using oligonucleotide array-based comparative genomic hybridization10.1016/j.cancergencyto.2009.03.009 ↗
23. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability10.1016/S0092-8674(01)00504-9 ↗
24. Telomere erosion and senescence in human articular cartilage chondrocytes10.1093/gerona/56.4.B172 ↗
25. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples
26. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro10.1006/abio.1999.4085 ↗
27. Premature chromosome condensation in humans associated with microcephaly and mental retardation: a novel autosomal recessive condition10.1086/339518 ↗
28. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels10.1016/0092-8674(82)90027-7 ↗
29. Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes10.1242/jcs.108.5.1991 ↗
30. Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes10.1016/S0006-291X(02)00223-1 ↗
31. Gene expression profiling of human articular cartilage grafts generated by tissue engineering10.1016/j.biomaterials.2006.02.017 ↗
32. Engineering of cartilage tissue using bioresorbable polymer carriers in perfusion culture10.1016/0142-9612(94)90224-0 ↗
33. Cartilage oligomeric matrix protein (COMP) and collagen IX are sensitive markers for the differentiation state of articular primary chondrocytes10.1042/bj3580017 ↗
34. Human polymer-based cartilage grafts for the regeneration of articular cartilage defects10.1016/j.tice.2007.05.002 ↗
35. Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results10.1186/ar2638 ↗
36. Chondrocyte transplantation in PGLA/polydioxanone fleece
37. Cartilage reconstruction in head and neck surgery: comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J ↗
38. Fetal and placenta chromosome constitution in 237 pregnancy losses10.1016/S0003-3995(01)01042-5 ↗
39. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions10.1016/0165-4608(93)90080-6 ↗
40. Chromosome preparations of chondrocytes cultured from human cartilages10.1002/ajmg.1320060212 ↗
41. Measurements of cellular viability. A comparative study of neutral red and radioactive sulfate in the examination of the viability of cartilage10.1097/00006534-196009000-00003 ↗
42. Decreased length of telomeric DNA sequences and increased numerical chromosome aberrations in human osteoarthritic chondrocytes10.1016/j.mrfmmm.2011.01.007 ↗
43. Clonal chromosome aberrations are present in vivo in synovia and osteophytes from patients with osteoarthritis10.1007/s004390050631 ↗
44. Evidence of somatic mutations in osteoarthritis10.1007/s004390050278 ↗
45. Chromosomal abnormalities in non-neoplastic renal tissue10.1016/0165-4608(95)00035-6 ↗
46. Atherosclerotic plaque as a benign tumor?10.1016/0165-4608(90)90037-B ↗
47. Trisomy 7 in nonneoplastic focal steatosis of the liver10.1016/0165-4608(92)90058-G ↗
48. Trisomy 7 in nonneoplastic cells10.1002/gcc.2870060402 ↗
49. Sex chromosome loss, micronuclei, sister chromatid exchange and aging: a study including 16 centenarians10.1016/S1383-5718(01)00279-0 ↗
50. Trisomy 7 accumulates with age in solid tumors and non-neoplastic synovia10.1002/1098-2264(2000)9999:9999<::AID-GCC1096>3.0.CO;2-C ↗
51. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage10.1371/journal.pone.0013246 ↗
52. Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells10.1016/j.yexcr.2004.02.026 ↗